Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials.
Implications of key trials in advanced nonsmall cell lung cancer.
Jaw, Edentulous, Partially
Polyhydroxyethyl Methacrylate
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Implications of key trials in advanced nonsmall cell lung cancer.
Implications of key trials in advanced nonsmall cell lung cancer. Cancer. 2010 Mar 01; 116(5):1155-64.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Carcinoma, Non-Small-Cell Lung
Cetuximab
Clinical Trials, Phase III as Topic
Drug Delivery Systems
Humans
Lung Neoplasms
Patient Selection
Treatment Outcome